# FDA 483 - Koriand'r Williams, M.D. - December 22, 2021

Source: https://www.keypedia.com/records/483/koriandr-williams-md/4bf837ed-ea57-4487-8a62-45a026372990

> FDA 483 for Koriand'r Williams, M.D. on December 22, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Koriand'r Williams, M.D.
- Inspection Date: 2021-12-22
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: Koriand'r Williams, M.D. in Houston, TX, a clinical investigator, was cited for significant deficiencies in conducting and supervising clinical investigations. The inspection revealed failures in ensuring accurate subject data, proper documentation of adverse findings, and adherence to investigational plans and standard operating procedures. These issues indicate a lack of oversight and proper record-keeping, potentially compromising study integrity.

## Related Officers

- [Anya D. Lockett-Evans](https://www.keypedia.com/people/anya-d-lockett-evans/afddc255-78ab-472c-9a69-f4cb9967f180)
- [Habacuc V. Barrera](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)

Company: https://www.keypedia.com/companies/koriandr-williams-md/01f43df1-6195-4a2b-911c-2389644fe755

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab